Signal active
Organization
Contact Information
Overview
Valeritas is a medical technology company committed to developing and commercializing innovative drug delivery solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of diabetes.
Valeritas' medical technologies portfolio is headlined by the h-Patch technology. The first use of the h-Patch technology will be the V-Go disposable insulin delivery device for continuous delivery both at a preset basal rate and for on-demand bolus dosing at mealtimes.
The V-Go is a simple-to-use, once-daily, disposable insulin delivery device that provides a preset basal rate and on-demand bolus dosing for mealtime coverage via a mealtime insulin. The V-Go will enable the millions suffering from Type 2 diabetes to conveniently and discreetly deliver insulin throughout the day bolus dose on-demand around mealtimes.
The h-Patch technology is also being developed to serve as a launching platform for applications across a wide spectrum of medical needs.
About
Biotechnology, Health Care, Medical Device, Diabetes
2006
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Valeritas headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device, Diabetes sector. The company focuses on Biotechnology and has secured $34.1B in funding across 96 round(s). With a team of 51-100 employees, Valeritas is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - Valeritas, raised $150.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
6
10
0
$355.0M
Details
4
Valeritas has raised a total of $355.0M in funding over 4 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2011 | Early Stage Venture | 10.0M | ||
2008 | Early Stage Venture | 50.0M | ||
2014 | Late Stage Venture | 45.0M | ||
2011 | Late Stage Venture | 150.0M |
Investors
Valeritas is funded by 48 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Valeritas | - | FUNDING ROUND - Valeritas | 150.0M |
Welsh Carson Anderson & Stowe | - | FUNDING ROUND - Welsh Carson Anderson & Stowe | 150.0M |
Valeritas | - | FUNDING ROUND - Valeritas | 150.0M |
Agate Medical Investments | - | FUNDING ROUND - Agate Medical Investments | 150.0M |
Recent Activity
There is no recent news or activity for this profile.